The results indicate that baseline chemerin quantities were not predictive for weight loss-associated dynamics of body fat percentage (Figure 5A) and liver fibrosis—as was displayed by the NAFLD fibrosis score and FIB4 (Figure 5B,C)—in LCD patients within 12 months. This evidence concerns the gene RARRES2 and Hepatic fibrosis.